Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form SB-2 of our report dated July 14, 2006 relating to the consolidated financial statements of MIV Therapeutics, Inc., and to the reference to our firm under the caption "Experts" in the related Prospectus of MIV Therapeutics, Inc., for the registration of up to 25,351,000 shares of its common stock and 13,303,000 transferable common stock purchase warrants.
"DMCL"
Dale Matheson Carr-Hilton LaBonteLLP
DMCL Chartered Accountants
Vancouver, Canada
July 13, 2007
